Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism

Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism

Purpose: Aldosterone-producing adenoma (APA) is the main curable cause of endocrine hypertension cause of primary aldosteronism (PA) and it is in up to 66% of all cases investigated with adrenal vein sampling (AVS). Mutations in the KCNJ5 potassium channel involve up to 70% of APA and cause the most...

Full description

Bibliographic Details
Main Authors: Giuseppe Maiolino, Giulio Ceolotto, Michele Battistel, Giulio Barbiero, Maurizio Cesari, Laurence Amar, Brasilina Caroccia, Roberto Padrini, Michel Azizi, Gian Paolo Rossi
Format: Article
Language:English
Published: Taylor & Francis Group 2018-07-01
Series:Blood Pressure
Subjects:
macrolides
primary aldosteronism
kcnj5 potassium channel
aldosterone-producing adenoma
Online Access:http://dx.doi.org/10.1080/08037051.2018.1436961

Internet

http://dx.doi.org/10.1080/08037051.2018.1436961

Similar Items